公开(公告)号：US11938162B2

公开(公告)日：2024-03-26

申请号：US16965754

申请日：2018-10-30

Applicant: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Jung Hyun Kim

IPC: A61P27/04 ,  A61K36/00 ,  A61K36/54

CPC classification number: A61K36/54 ,  A61P27/04 ,  A61K2236/331

Abstract: Provided is a composition for preventing, alleviating or treating dry eye syndrome, containing an Aucuba japonica extract as an active ingredient. The composition containing an Aucuba japonica extract can be effectively used in the prevention, alleviation or treatment of dry eye syndrome.

公开(公告)号：US20210378545A1

公开(公告)日：2021-12-09

申请号：US16330597

申请日：2018-11-08

Applicant: MPROS ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Jae Joong IM

IPC: A61B5/08 ,  A61B5/259 ,  A61B5/145 ,  A61B5/00 ,  A61B5/022

Abstract: The present invention relates to a respiratory sensing device attached to a patient's body and configured to acquire information regarding the patient's respiratory condition by sensing a vibration generated due to the patient's respiration using the piezoelectric effect and a respiratory monitoring system configured to output the acquired information regarding the patient's respiratory state.

公开(公告)号：US11071748B2

公开(公告)日：2021-07-27

申请号：US16340639

申请日：2017-10-11

Applicant: Industrial Cooperation Foundation Chonbuk National University

Inventor： Uh Hyun Kim ,  Dae Ryoung Park ,  Kwang Hyun Park

IPC: A61K31/496 ,  A61P21/00 ,  A61K31/7076 ,  A61P17/02 ,  A61K9/00

Abstract: When using a pharmaceutical composition for preventing or treating malignant hyperthermia, containing NAADP antagonists, of the present invention, malignant hyperthermia can be effectively prevented or treated through the inhibition of an oxygen consumption rate abnormal increase, which is associated with a ryanodine receptor (RYR) of skeletal muscles. In addition, the present invention can be used even after the onset of malignant hyperthermia and can inhibit an oxygen consumption rate abnormal increase even at concentrations lower than those of conventional agents for treating malignant hyperthermia, thereby enabling conventional agents for treating malignant hyperthermia to be replaced, and can be stably used, thereby being effectively usable in relevant industries. Furthermore, when using a skin regenerating composition, containing cADPR or NAADP antagonists, of the present invention, the skin can be protected from skin cell damage caused by UV-B of ultraviolet rays, and the skin regenerating composition has an excellent ability to recover and regenerate damaged skin and has no side effects on the same, thereby being usable in various forms such as a skin external preparation, a pharmaceutical composition, a cosmetic composition, and a food composition.

公开(公告)号：US20200381088A1

公开(公告)日：2020-12-03

申请号：US16960369

申请日：2019-01-08

Applicant: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Min Gul KIM ,  Ji Hyoung LEE ,  Sang Un JEONG

IPC: G16H10/20 ,  H04L9/08 ,  G06Q50/18 ,  G06Q30/00 ,  G16H20/10 ,  G16H10/60 ,  G06Q50/26 ,  G16H40/20

Abstract: A method is disclosed including: allowing a contract research organization device to generate clinical trial information and transmit the information to a blockchain server; allowing the server to register the information, and assign a first private key and a first public key to a set site device and transmit the assigned keys to the site device in response to a request from the organization device; allowing the server to complete applicant authentication using a second private key assigned to an applicant for a clinical trial; allowing the site device to confirm previous participation information of the applicant; and allowing the site device to perform the clinical trial based on the previous participation information, encrypt a performance result of the clinical trial using the first public key, a second public key corresponding to the second private key, and the second private key, and transmit the encrypted performance result to the server.

公开(公告)号：US10824033B2

公开(公告)日：2020-11-03

申请号：US15826278

申请日：2017-11-29

Applicant: LG DISPLAY CO., LTD. ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Jihoon Lee ,  Hyungmin Kim ,  Jongyoon Kim ,  Jonghoon Woo ,  Chiwan Kim ,  Sungeui Shin ,  Seongil Kim ,  Jaebin Song

IPC: G02F1/1334 ,  G02F1/1347 ,  G02F1/137

Abstract: A mirror cell and a display device are disclosed. The mirror cell includes a lower substrate, which includes a lower alignment film and a lower electrode, an upper substrate, which opposes the lower substrate and includes an upper alignment film and an upper electrode, a liquid crystal layer, which is disposed between the lower alignment film and the upper alignment film and includes a cholesteric liquid crystal and a reactive liquid crystal, and a reactive layer, which is disposed between the upper alignment film and the liquid crystal layer and includes a same kind of reactive liquid crystals as the reactive liquid crystal in the liquid crystal layer.

公开(公告)号：US10678095B2

公开(公告)日：2020-06-09

申请号：US15439179

申请日：2017-02-22

Applicant: SAMSUNG DISPLAY CO., LTD. ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Heung Shik Park ,  Shin Woong Kang ,  Ki Chul Shin ,  Myong Hoon Lee

IPC: C09K19/56 ,  G02F1/1337 ,  G02F1/1341

Abstract: A display device includes: a display panel including an insulating substrate, a first electrode disposed on the insulating substrate, and a second electrode disposed on the insulating substrate and disposed to be insulated from the first electrode; a liquid crystal layer disposed on the display panel; and an alignment-inducing layer disposed between the display panel and the liquid crystal layer, wherein the alignment-inducing layer includes a compound having a structure represented by Chemical Formula 1-A: In Chemical Formula 1-A above, R1 is a hydrophilic group, R2 is a hydrogen atom, and A is an alkylene group of 1 to 20 carbon atoms, an alkyleneoxy group of 1 to 20 carbon atoms, or a single bond.

公开(公告)号：US10292969B2

公开(公告)日：2019-05-21

申请号：US15547030

申请日：2015-12-16

Applicant: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY ,  CHONBUK NATIONAL UNIVERSITY HOSPITAL

Inventor： Yong Chul Lee ,  So Ri Kim

IPC: A61K31/429 ,  A61K31/4178 ,  A61K31/428 ,  A23L33/10 ,  A23L29/00

Abstract: The present invention relates to a composition for prevention or treatment of bronchial asthma comprising a PKR inhibitor as an active ingredient. The PKR inhibitor and derivatives thereof according to the present invention can be used as a pharmaceutical for prevention, amelioration or treatment of bronchial asthma and as a supplementary health food because the PKR inhibitor and derivatives thereof reduce the total counts of inflammatory cells, eosinophils, neutrophils and lymphocytes in bronchoalveolar lavage fluid of neutrophilic severe asthma-induced mice, reduce airway inflammation and airway hyper-responsiveness, and reduce inflammatory mediators.

公开(公告)号：US10126599B2

公开(公告)日：2018-11-13

申请号：US14661974

申请日：2015-03-18

Applicant: Samsung Display Co., Ltd. ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Shin Woong Kang ,  Kwang Un Jeong ,  Byung Wook Ahn ,  Keun Chan Oh ,  Chang Hun Lee

IPC: G02F1/1337 ,  C09K19/56 ,  C09K19/52

Abstract: A liquid crystal device that includes two substrates that face each other, a liquid crystal cell interposed between the two substrates, and a liquid crystal alignment layer interposed between the liquid crystal cell and at least one of the two substrates, the liquid crystal alignment layer includes a plurality of spherical or spherical-like core particles having a diameter of 10 nm to 1 μm.

公开(公告)号：US20180167314A1

公开(公告)日：2018-06-14

申请号：US15488546

申请日：2017-04-17

Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Seo Hyang KIM ,  Chong Kwon KIM ,  GIHWAN CHO ,  Min-Joon KIM

IPC: H04L12/721 ,  H04L12/775

CPC classification number: H04L45/14 ,  H04L45/127 ,  H04W40/04 ,  H04W84/18 ,  Y02D50/30

Abstract: Disclosed herein are a destination oriented directed acyclic graph (DODAG) structure-based backpressure routing apparatus and method for multi-hop communication in a network including a plurality of nodes. The DODAG structure-based backpressure routing apparatus includes: means for selecting at least one of adjacent nodes of each node as a head node group based on a rank value allocated to the each node; and M means for, when a message reaches a certain node, selecting one node, directed to a direction of a destination node, from the head node group, and transferring the message to the selected node.

公开(公告)号：US20180149919A1

公开(公告)日：2018-05-31

申请号：US15826278

申请日：2017-11-29

Applicant: LG DISPLAY CO., LTD. ,  INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY

Inventor： Jihoon LEE ,  Hyungmin KIM ,  Jongyoon KIM ,  Jonghoon WOO ,  Chiwan KIM ,  Sungeui SHIN ,  Seongil KIM ,  Jaebin SONG

IPC: G02F1/1335 ,  G02F1/1337 ,  G02F1/1343

Abstract: A mirror cell and a display device are disclosed. The mirror cell includes a lower substrate, which includes a lower alignment film and a lower electrode, an upper substrate, which opposes the lower substrate and includes an upper alignment film and an upper electrode, a liquid crystal layer, which is disposed between the lower alignment film and the upper alignment film and includes a cholesteric liquid crystal and a reactive liquid crystal, and a reactive layer, which is disposed between the upper alignment film and the liquid crystal layer and includes a same kind of reactive liquid crystals as the reactive liquid crystal in the liquid crystal layer.